{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:44:39Z","timestamp":1746445479357},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1245\/s10434-013-3232-y","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T14:27:48Z","timestamp":1377613668000},"page":"716-724","source":"Crossref","is-referenced-by-count":6,"title":["Valproic Acid Sensitizes TRAIL-Resistant Anaplastic Thyroid Carcinoma Cells to Apoptotic Cell Death"],"prefix":"10.1245","volume":"20","author":[{"given":"Hyun-Young","family":"Cha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bok-Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Seob","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Won","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Sil","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,28]]},"reference":[{"issue":"7","key":"3232_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1470-2045(02)00787-8","volume":"3","author":"L Vini","year":"2002","unstructured":"Vini L, Harmer C. Management of thyroid cancer. Lancet Oncol. 2002;3(7):407\u201314.","journal-title":"Lancet Oncol."},{"key":"3232_CR2","doi-asserted-by":"crossref","unstructured":"Tan RK, Finley RK 3rd, Driscoll D, Bakamjian V, Hicks WL Jr, Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck. 1995;17(1):41\u20137; discussion 47\u20138.","DOI":"10.1002\/hed.2880170109"},{"issue":"1","key":"3232_CR3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00001622-200301000-00012","volume":"15","author":"JL Pasieka","year":"2003","unstructured":"Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol. 2003;15(1):78\u201383.","journal-title":"Curr Opin Oncol."},{"issue":"5","key":"3232_CR4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1210\/jc.2006-2157","volume":"92","author":"C Conticello","year":"2007","unstructured":"Conticello C, Adamo L, Giuffrida R, et al. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death. J Clin Endocrinol Metab. 2007;92(5):1938\u201342.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"3232_CR5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1677\/ERC-08-0021","volume":"15","author":"Y Arlot-Bonnemains","year":"2008","unstructured":"Arlot-Bonnemains Y, Baldini E, Martin B, et al. Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines. Endocr Relat Cancer. 2008;15(2):559\u201368.","journal-title":"Endocr Relat Cancer."},{"issue":"1","key":"3232_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/ERC-10-0234","volume":"18","author":"S Libertini","year":"2011","unstructured":"Libertini S, Abagnale A, Passaro C, et al. AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947. Endocr Relat Cancer. 2011;18(1):129\u201341.","journal-title":"Endocr Relat Cancer."},{"issue":"3","key":"3232_CR7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12020-012-9665-4","volume":"42","author":"A Wunderlich","year":"2012","unstructured":"Wunderlich A, Roth S, Ramaswamy A, et al. Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer. Endocrine. 2012;42(3):637\u201346.","journal-title":"Endocrine."},{"issue":"30","key":"3232_CR8","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/sj.onc.1203679","volume":"19","author":"M Ahmad","year":"2000","unstructured":"Ahmad M, Shi Y. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Oncogene. 2000;19(30):3363\u201371.","journal-title":"Oncogene."},{"issue":"1","key":"3232_CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"HN LeBlanc","year":"2003","unstructured":"LeBlanc HN, Ashkenazi A. Apo2L\/TRAIL and its death and decoy receptors. Cell Death Differ. 2003;10(1):66\u201375.","journal-title":"Cell Death Differ."},{"issue":"2","key":"3232_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1044-579X(02)00131-1","volume":"13","author":"N Ozoren","year":"2003","unstructured":"Ozoren N, El-Deiry WS. Cell surface death receptor signaling in normal and cancer cells. Semin Cancer Biol. 2003;13(2):135\u201347.","journal-title":"Semin Cancer Biol."},{"issue":"13","key":"3232_CR11","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.yexcr.2012.04.003","volume":"318","author":"ES Sung","year":"2012","unstructured":"Sung ES, Park KJ, Choi HJ, Kim CH, Kim YS. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Exp Cell Res. 2012;318(13):1564\u201376.","journal-title":"Exp Cell Res."},{"issue":"8","key":"3232_CR12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cellsig.2011.03.017","volume":"23","author":"S Kahana","year":"2011","unstructured":"Kahana S, Finniss S, Cazacu S, et al. Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCepsilon-dependent downregulation of AKT and XIAP expressions. Cell Signal. 2011;23(8):1348\u201357.","journal-title":"Cell Signal."},{"issue":"10","key":"3232_CR13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10495-010-0521-9","volume":"15","author":"ES Sung","year":"2010","unstructured":"Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells. Apoptosis. 2010;15(10):1256\u201369.","journal-title":"Apoptosis."},{"issue":"12","key":"3232_CR14","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1535-7163.MCT-10-0582","volume":"9","author":"RK Srivastava","year":"2010","unstructured":"Srivastava RK, Kurzrock R, Shankar S. MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. Mol Cancer Ther. 2010;9(12):3254\u201366.","journal-title":"Mol Cancer Ther."},{"issue":"2A","key":"3232_CR15","first-page":"855","volume":"28","author":"G Iacomino","year":"2008","unstructured":"Iacomino G, Medici MC, Russo GL. Valproic acid sensitizes K562 erythroleukemia cells to TRAIL\/Apo2L-induced apoptosis. Anticancer Res. 2008;28(2A):855\u201364.","journal-title":"Anticancer Res."},{"issue":"5","key":"3232_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00432-010-0952-2","volume":"137","author":"K Brautigam","year":"2011","unstructured":"Brautigam K, Biernath-Wupping J, Bauerschlag DO, et al. Combined treatment with TRAIL and PPAR\u03b3 ligands overcomes chemoresistance of ovarian cancer cell lines. J Cancer Res Clin Oncol. 2011;137(5):875\u201386.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"1","key":"3232_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00280-002-0465-z","volume":"50","author":"A Munshi","year":"2002","unstructured":"Munshi A, McDonnell TJ, Meyn RE. Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells. Cancer Chemother Pharmacol. 2002;50(1):46-52.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"37","key":"3232_CR18","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1038\/sj.onc.1207830","volume":"23","author":"S Nakata","year":"2004","unstructured":"Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T. Histone deacetylase inhibitors upregulate death receptor 5\/TRAIL-R2 and sensitize apoptosis induced by TRAIL\/APO2-L in human malignant tumor cells. Oncogene. 2004;23(37):6261\u201371.","journal-title":"Oncogene."},{"issue":"2","key":"3232_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gde.2006.02.015","volume":"16","author":"KP Nightingale","year":"2006","unstructured":"Nightingale KP, O\u2019Neill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Gen Dev. 2006;16(2):125\u201336.","journal-title":"Curr Opin Genet Dev."},{"issue":"1","key":"3232_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0959-437X(99)80006-9","volume":"9","author":"T Kouzarides","year":"1999","unstructured":"Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Gen Dev. 1999;9(1):40\u20138.","journal-title":"Curr Opin Gen Dev."},{"issue":"1","key":"3232_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/bj2650023","volume":"265","author":"A Csordas","year":"1990","unstructured":"Csordas A. On the biological role of histone acetylation. Biochem J. 1990;265(1):23\u201338.","journal-title":"Biochem J."},{"issue":"11","key":"3232_CR22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.yexcr.2012.02.005","volume":"318","author":"S Fulda","year":"2012","unstructured":"Fulda S. Histone deacetylase (HDAC) inhibitors and regulation of TRAIL-induced apoptosis. Exp Cell Res. 2012;318(11):1208\u201312.","journal-title":"Exp Cell Res."},{"issue":"8","key":"3232_CR23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bcp.2011.11.010","volume":"83","author":"P Perego","year":"2012","unstructured":"Perego P, Zuco V, Gatti L, Zunino F. Sensitization of tumor cells by targeting histone deacetylases. Biochem Pharmacol. 2012;83(8):987\u201394.","journal-title":"Biochem Pharmacol."},{"issue":"32","key":"3232_CR24","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1073\/pnas.0801868105","volume":"105","author":"AJ Frew","year":"2008","unstructured":"Frew AJ, Lindemann RK, Martin BP, et al. Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist. Proc Natl Acad Sci USA. 2008;105(32):11317\u201322.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"3232_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2008.03.037","volume":"269","author":"JS Carew","year":"2008","unstructured":"Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett. 2008;269(1):7\u201317.","journal-title":"Cancer Lett."},{"key":"3232_CR26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/ERC-12-0405","volume":"20","author":"BS Lee","year":"2013","unstructured":"Lee BS, Cha HY, Shin YS, Kim YS, Kim CH. AY4, an agonistic anti-death receptor 4 monoclonal antibody, induces apoptotic cell death in anaplastic thyroid cancer cells via down-regulation of Bcl-xL with reactive oxygen species generation. Endocr Relat Cancer. 2013;20:283\u201391.","journal-title":"Endocr Relat Cancer."},{"issue":"1","key":"3232_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2012.02.007","volume":"322","author":"BS Lee","year":"2012","unstructured":"Lee BS, Kang SU, Hwang HS, et al. An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation. Cancer Lett. 2012;322(1):45\u201357.","journal-title":"Cancer Lett."},{"issue":"1","key":"3232_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2008.05.048","volume":"271","author":"YC Lim","year":"2008","unstructured":"Lim YC, Park HY, Hwang HS, et al. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett. 2008;271(1):140\u201352.","journal-title":"Cancer Lett."},{"issue":"12","key":"3232_CR29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hed.21383","volume":"32","author":"CH Kim","year":"2010","unstructured":"Kim CH, Koh YW, Han JH, et al. c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Head Neck. 2010;32(12):1655\u201364.","journal-title":"Head Neck."},{"issue":"24","key":"3232_CR30","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1128\/MCB.22.24.8571-8579.2002","volume":"22","author":"F Tang","year":"2002","unstructured":"Tang F, Tang G, Xiang J, Dai Q, Rosner MR, Lin A. The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2002;22(24):8571\u20139.","journal-title":"Mol Cell Biol."},{"issue":"1","key":"3232_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.taap.2007.11.032","volume":"228","author":"DE Muscarella","year":"2008","unstructured":"Muscarella DE, Bloom SE. The contribution of c-Jun N-terminal kinase activation and subsequent Bcl-2 phosphorylation to apoptosis induction in human B-cells is dependent on the mode of action of specific stresses. Toxicol Appl Pharmacol. 2008;228(1):93\u2013104.","journal-title":"Toxicol Appl Pharmacol."},{"issue":"6824","key":"3232_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37\u201340.","journal-title":"Nature."},{"issue":"18","key":"3232_CR33","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1158\/1078-0432.CCR-06-0367","volume":"12","author":"QT Luong","year":"2006","unstructured":"Luong QT, O\u2019Kelly J, Braunstein GD, Hershman JM, Koeffler HP. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo. Clin Cancer Res. 2006;12(18):5570\u20137.","journal-title":"Clin Cancer Res."},{"issue":"2","key":"3232_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10637-005-5854-9","volume":"23","author":"J Sonnemann","year":"2005","unstructured":"Sonnemann J, Gange J, Kumar KS, Muller C, Bader P, Beck JF. Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. Investig New Drugs. 2005;23(2):99\u2013109.","journal-title":"Investig New Drugs."},{"issue":"2","key":"3232_CR35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.yexcr.2004.04.038","volume":"298","author":"V Chopin","year":"2004","unstructured":"Chopin V, Slomianny C, Hondermarck H, Le Bourhis X. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors\u2019 signaling and requires P21(waf1). Exp Cell Res. 2004;298(2):560\u201373.","journal-title":"Exp Cell Res."},{"issue":"11","key":"3232_CR36","first-page":"4450","volume":"61","author":"M Fan","year":"2001","unstructured":"Fan M, Goodwin ME, Birrer MJ, Chambers TC. The c-Jun NH(2)-terminal protein kinase\/AP-1 pathway is required for efficient apoptosis induced by vinblastine. Cancer Res. 2001;61(11):4450\u20138.","journal-title":"Cancer Res."},{"issue":"8","key":"3232_CR37","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/j.1582-4934.2009.00844.x","volume":"14","author":"V Sharma","year":"2010","unstructured":"Sharma V, Koul N, Joseph C, Dixit D, Ghosh S, Sen E. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity. J Cell Mol Med. 2010;14(8):2151\u201361.","journal-title":"J Cell Mol Med."},{"issue":"20","key":"3232_CR38","first-page":"6825","volume":"63","author":"D Xiao","year":"2003","unstructured":"Xiao D, Pinto JT, Soh JW, et al. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res. 2003;63(20):6825\u201337.","journal-title":"Cancer Res."},{"issue":"2","key":"3232_CR39","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.jss.2011.01.015","volume":"167","author":"M Benoit","year":"2011","unstructured":"Benoit M, Dormond-Meuwly A, Demartines N, Dormond O. Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells. J Surg Res. 2011;167(2):e193\u20138.","journal-title":"J Surg Res."},{"issue":"1","key":"3232_CR40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.M309476200","volume":"279","author":"H Higuchi","year":"2004","unstructured":"Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ. Bile acids up-regulate death receptor 5\/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem. 2004;279(1):51\u201360.","journal-title":"J Biol Chem."},{"issue":"4","key":"3232_CR41","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00726-012-1249-3","volume":"43","author":"MK Hwang","year":"2012","unstructured":"Hwang MK, Ryu BJ, Kim SH. AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules. Amino Acids. 2012;43(4):1679\u201387.","journal-title":"Amino Acids."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3232-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-3232-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3232-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:23:06Z","timestamp":1559632986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-3232-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,28]]},"references-count":41,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3232"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-3232-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,28]]}}}